This inventor holds 2 USPTO granted patents. Top assignee: Sanofi-Synthelabo. Active years: 2000-2001.
Company Filing History:
Years Active: 2000-2001
Title: The Innovative Contributions of Sonia Arbilla
Introduction
Sonia Arbilla is a prominent inventor based in Paris, France. She has made significant contributions to the field of medicine, particularly in the development of treatments for specific health conditions. With a total of 2 patents to her name, her work reflects a commitment to advancing medical science.
Latest Patents
Among her latest patents is the innovative use of sulphonanilide derivatives to obtain a medicine for treating retrograde ejaculation or aspermia. This patent focuses on the application of a compound with the formula (I). Additionally, she has developed a patent for the use of mizolastine in treating inflammatory diseases associated with various conditions. These patents highlight her dedication to addressing complex medical issues.
Career Highlights
Sonia Arbilla is currently associated with Sanofi-Synthelabo, a leading pharmaceutical company. Her role at the company allows her to leverage her expertise in developing groundbreaking medical solutions. Her work has not only contributed to her personal achievements but has also advanced the company's mission to improve patient care.
Collaborations
Throughout her career, Sonia has collaborated with notable professionals in her field, including Itzchak Angel and Luc Even. These partnerships have fostered an environment of innovation and have led to the successful development of her patents.
Conclusion
Sonia Arbilla's contributions to the field of medicine through her patents and collaborations exemplify her role as a leading inventor. Her work continues to inspire advancements in medical treatments, making a significant impact on healthcare.